ArticleClinical hematology international2020

Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma.

Kristian T Andersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.